Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1994-2-24
|
pubmed:abstractText |
The effect of indomethacin 25 mg 3 times daily during the first 2 postoperative weeks in preventing heterotopic bone formation after cemented total hip arthroplasty was investigated in a randomized, double-blind and placebo-controlled clinical trial on 57 patients. 16 patients were secondarily excluded, leaving 19 patients in the indomethacin group and 22 patients in the placebo group. Evaluated from the 3-month radiographs, 18/19 indomethacin patients developed either no or only the milder Grade 1 ossification. In contrast, 11/22 placebo patients developed Grade 2 or 3 ossifications. Our observations favor indomethacin prophylaxis for 2 weeks in cemented arthroplasty of the hip.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0001-6470
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
639-42
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8291408-Aged,
pubmed-meshheading:8291408-Aged, 80 and over,
pubmed-meshheading:8291408-Double-Blind Method,
pubmed-meshheading:8291408-Female,
pubmed-meshheading:8291408-Hip Prosthesis,
pubmed-meshheading:8291408-Humans,
pubmed-meshheading:8291408-Indomethacin,
pubmed-meshheading:8291408-Male,
pubmed-meshheading:8291408-Middle Aged,
pubmed-meshheading:8291408-Ossification, Heterotopic,
pubmed-meshheading:8291408-Postoperative Complications
|
pubmed:year |
1993
|
pubmed:articleTitle |
Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties.
|
pubmed:affiliation |
Orthopedic Hospital, University of Aarhus, Denmark.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|